drugset
Drugs / Human Allogeneic Umbilical Cord Blood Mononuclear Cells
last change Sep 2018 re-read 3 minutes ago

Human Allogeneic Umbilical Cord Blood Mononuclear Cells

also known as hUCBMCs
Developed for
spinal cord injury
Investigated by
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation · Sklifosovsky Institute of Emergency Care

Trials 1

today NCT04331405 · Ph 1/2
201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT04331405 Mar 2013 → Mar 2018 spinal cord injury Sklifosovsky Institute of Emergency Care Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Human Allogeneic Umbilical Cord Blood Mononuclear Cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT04331405 ↗
Known as hUCBMCs “Human Allogeneic Umbilical Cord Blood Mononuclear Cells (hUCBMCs)” NCT04331405 ↗
Route Intravenous “systemic (i.v.) allogeneic human umbilical cord blood mononuclear cell infusions” NCT04331405 ↗